...We Welcome You To The Resverlogix HUB In The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Free
Message: Another day another options exercise, this time by Bradley Cann 33,800 @$1.28

Three days in row now, Friday Monday Tuesday....maybe there will be on for Wednesday reported tomorrow.

https://www.canadianinsider.com/node/7?menu_tickersearch=RVX+%7C+Resverlogix

Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 10/18 Jul 6/18 Cann, Aaron Bradley Direct Ownership Common Shares 51 - Exercise of options 33,800 $1.28
Jul 10/18 Jul 6/18 Cann, Aaron Bradley Direct Ownership Options 51 - Exercise of options -33,800  
Jul 9/18 Jul 4/18 Kulikowski, Ewelina Direct Ownership Common Shares 51 - Exercise of options 9,900 $1.28
Jul 9/18 Jul 4/18 Kulikowski, Ewelina Direct Ownership Options 51 - Exercise of options -9,900  
Jul 6/18 Jul 3/18 McNeill, Kelly Bret Direct Ownership Common Shares 51 - Exercise of options 30,000 $1.37
Jul 6/18 Jul 3/18 McNeill, Kelly Bret Direct Ownership Options 51 - Exercise of options -30,000
Share
New Message
Please login to post a reply